Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)
TWD 13.6
(-14.73%)
TWD 13.6
(-14.73%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 514.65 Million TWD | 11.37% |
| 2022 | 462.12 Million TWD | -2.15% |
| 2021 | 472.29 Million TWD | 1.67% |
| 2020 | 464.55 Million TWD | 171955.56% |
| 2019 | 270 Thousand TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 470.5 Million TWD | -8.58% |
| 2024 Q2 | 470.5 Million TWD | 0.0% |
| 2023 FY | 514.65 Million TWD | 11.37% |
| 2023 Q2 | 502.11 Million TWD | 0.0% |
| 2023 Q1 | 502.11 Million TWD | 8.65% |
| 2023 Q3 | 514.65 Million TWD | 2.5% |
| 2023 Q4 | 514.65 Million TWD | 0.0% |
| 2022 Q3 | 462.12 Million TWD | 0.0% |
| 2022 Q4 | 462.12 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -7258.464% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 11.797% |
| Level Biotechnology Inc. | 273.2 Million TWD | -88.378% |
| Sagittarius Life Science Corp | 137.82 Million TWD | -273.412% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | -160.621% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 61.241% |
| GlycoNex Incorporation | 276.39 Million TWD | -86.199% |
| VBI | 21.25 Million TWD | -2321.773% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | -64.055% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -2324.625% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | -39.725% |
| Visgeneer Inc. | 185.6 Million TWD | -177.283% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 61.106% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 29.787% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -329.377% |
| Neith Corporation | 17.43 Million TWD | -2852.165% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 77.087% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -7676.534% |
| Enimmune corporation | 173.46 Million TWD | -196.692% |
| TaiRx, Inc. | 60.62 Million TWD | -748.909% |
| CHO Pharma, Inc. | 110.83 Million TWD | -364.352% |
| EirGenix Inc. | 1.14 Billion TWD | 55.056% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -359.588% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | -0.432% |
| Lin BioScience, Inc. | 167.73 Million TWD | -206.833% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -449.172% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -716.466% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | -312.615% |
| Lukas Biomedical Inc. | 161.05 Million TWD | -219.542% |
| RBC Bioscience Corporation | 513.08 Million TWD | -0.306% |
| BiOptic Inc. | 170.56 Million TWD | -201.737% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -1120.767% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -2113.077% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -1819.408% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 47.195% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -6355.733% |
| NaviFUS Corp. | 53.4 Million TWD | -863.748% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | -6.888% |
| Sinew Pharma Inc. | 39.71 Million TWD | -1195.893% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -786.733% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | -41.203% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | -126.027% |
| AP Biosciences Inc | 106.65 Million TWD | -382.561% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 85.421% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -1577.426% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | -162.59% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 66.651% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 40.601% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -5448.2% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -822.099% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | -120.919% |
| TCI GENE Inc. | 155.54 Million TWD | -230.863% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -1917.606% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -1014.566% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | -56.681% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -693.15% |
| PharmaEngine, Inc. | 91 Million TWD | -465.513% |
| Savior Lifetec Corporation | 457.95 Million TWD | -12.38% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -363.9% |
| OBI Pharma, Inc. | 650.44 Million TWD | 20.877% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | -31.688% |
| Acepodia, Inc. | 384.47 Million TWD | -33.859% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -501.558% |